Holmarc Opto-Mechatronics Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 21.4%
- Company has delivered good sales growth of 22.1% CAGR over last 5 years
- Company comfortably covers its interest (38.8x coverage)
- Company generates healthy free cash flow
- Company has a consistent dividend-paying track record
CONS
- Equity base is being diluted - shares outstanding up 39.6%
- Expensive relative to growth - PEG of 5.8
- Though reporting repeated profits, the company pays out little dividend (12.3%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| LENSKART | 694.05 | 184.20 | 120716.54 | 0.00 | 2284.30 | 3634.35 | 27141.80 | 1332.69 | 12.55 | 21.70 |
| POLYMED | 1723.80 | 55.45 | 17472.69 | 0.20 | 85.27 | -8.39 | 525.38 | 30.30 | 14.05 | 24.11 |
| MOLBIO | 1258.10 | 87.03 | 14498.34 | 0.00 | 527.44 | — | 4083.76 | — | 19.79 | 24.63 |
| 3BBLACKBIO | 1472.10 | 22.75 | 1263.45 | 0.34 | 8.98 | -28.99 | 33.49 | 50.59 | 26.03 | 25.45 |
| LAXMIDENTL | 200.40 | 35.70 | 1102.79 | 0.00 | 10.32 | 23.83 | 74.70 | 16.13 | 24.96 | 20.26 |
| HOLMARC | 109.00 | 26.84 | 109.55 | 0.46 | — | — | — | — | 18.50 | — |
| GKB | 66.13 | 10.28 | 33.33 | 0.00 | 1.85 | 387.99 | 33.04 | 2.26 | 8.82 | 7.97 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 16 | 21 | 29 | 33 | 37 | 42 | |
| 14 | 18 | 24 | 28 | 31 | 36 | |
| Operating Profit | 2 | 3 | 5 | 5 | 6 | 6 |
| OPM % | 9.69% | 13.88% | 17.53% | 15.88% | 15.70% | 15.28% |
| 0 | 0 | 1 | 0 | 1 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before Tax | 1 | 2 | 5 | 5 | 5 | 5 |
| Tax % | 29.31% | 29.86% | 26.03% | 24.93% | 24.32% | 22.72% |
| Net Profit | 1 | 2 | 4 | 3 | 4 | 4 |
| EPS | 34.40 | 77.60 | 4.95 | 3.42 | 3.72 | 4.06 |
| Dividend Payout % | 29.07% | 12.89% | 6.07% | 11.71% | 10.76% | 12.31% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 22%
- 3 Years:
- 13%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 43%
- 3 Years:
- 5%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -13%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 21%
- 3 Years:
- 16%
- Last Year:
- 14%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0 | 0 | 7 | 10 | 10 | 10 |
| 7 | 8 | 4 | 14 | 17 | 21 | |
| 2 | 2 | 1 | 0 | 0 | 1 | |
| Trade Payables | 0 | 0 | 0 | 0 | 1 | 1 |
| 3 | 3 | 3 | 3 | 4 | 5 | |
| Total Liabilities | 12 | 14 | 16 | 27 | 31 | 37 |
| 4 | 5 | 5 | 6 | 7 | 10 | |
| 1 | 2 | 2 | 3 | 5 | 6 | |
| 0 | 0 | 0 | 7 | 8 | 9 | |
| Cash & Bank | 1 | 2 | 2 | 9 | 10 | 11 |
| 6 | 5 | 7 | 2 | 1 | 2 | |
| Total Assets | 12 | 14 | 16 | 27 | 31 | 37 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 1 | 3 | 3 | 2 | 3 | 5 | |
| Cash from Investing | -1 | -2 | -0 | -2 | -2 | -3 |
| Cash from Financing | 0 | 0 | -1 | 7 | -0 | 0 |
| 0 | 1 | 1 | 7 | 1 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for HOLMARC
Loading news…
AI Stock Analyst
Holmarc Opto-Mechatronics Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account